Eva
Bandres Elizalde
Researcher to 2004
Hospital Miguel Servet
Zaragoza, EspañaPublications in collaboration with researchers from Hospital Miguel Servet (3)
2020
-
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
British Journal of Haematology, Vol. 189, Núm. 6, pp. 1064-1073
2011
-
Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma
BJU International, Vol. 107, Núm. 11, pp. 1833-1838
2007
-
Expresion del receptor de esteroides y xenobioticos (SXR) y del gen de multirresistencia drogas (MDR1) y de los polimorfismos de las enzimas GSTs, SULTs y CYP en tumores vesicates profundos, analisis de su expresion y correlación con otros factores pronósticos
Actas Urologicas Espanolas, Vol. 31, Núm. 10, pp. 1107-1116